2024. INTERLEUKIN-40 AS A PREDICTIVE TOOL OF RESPONSE TO TREATMENT FOR INSULIN RESISTANCE IN PATIENTS WITH TYPE 2 DIABETES. CAHIERS MAGELLANES-NS. 6, 2 (Aug. 2024), 3635–3642.